Monitoring the harm associated with use of anticoagulants in pediatric populations through trigger-based automated adverse-event detection

Jason T. Patregnani, Michael C. Spaeder, Valere Lemon, Yaser Diab, Darren Klugman, David Stockwell

Research output: Contribution to journalArticle

Abstract

Background: The safety profile of anticoagulants, which are being used with increasing frequency in pediatric populations, is not well studied. Automatic triggers built into electronic health record systems (EHR) have been shown to be an effective way to monitor for and identify medication errors. Anticoagulant-associated adverse events were examined through the use of an anticoagulant trigger panel. Methods: In a retrospective, five-year (September 2007-September 2012) observational study, four automated triggers were used to detect anticoagulant-related adverse events: activated partial thromboplastin time (aPTT) > 100 seconds in patients on an unfractionated heparin (UFH) infusion, International Normalized Ratio (INR) > 4, anti-factor Xa (anti-FXa) >1.5U/mL for patients on enoxaparin, and the documented use of protamine. Results: For the 1,664 triggers evaluated, 12 were associated with the aPTT trigger, only 1 of which was preventable. Receiver operator characteristic curve analysis indicated that increasing the aPTT trigger > 140 seconds would optimize sensitivity and specificity. The INR trigger identified four outpatients with adverse events. No adverse events were associated with the anti-FXa trigger. The protamine trigger identified 12 adverse events and was associated with more severe events. Minimal overlap was found with protamine and aPTT triggers. Conclusion: Laboratory- and medication-based triggers can be effective monitoring tools for anticoagulants. For patients receiving a UFH infusion, an aPTT cutoff value of > 140 seconds is more precise. We also found that protamine use as a trigger adds value to a trigger-based anticoagulant monitoring system. Continued improvement in the logic algorithms associated with the EHR-based trigger tool will allow expanded use of this tool in a clinical manner.

Original languageEnglish (US)
Pages (from-to)108-114
Number of pages7
JournalJoint Commission Journal on Quality and Patient Safety
Volume41
Issue number3
DOIs
StatePublished - Mar 1 2015
Externally publishedYes

Fingerprint

Partial Thromboplastin Time
Anticoagulants
Protamines
Pediatrics
Population
Factor Xa
International Normalized Ratio
Electronic Health Records
Heparin
Enoxaparin
Medication Errors
Observational Studies
Outpatients
Safety
Sensitivity and Specificity

ASJC Scopus subject areas

  • Leadership and Management

Cite this

Monitoring the harm associated with use of anticoagulants in pediatric populations through trigger-based automated adverse-event detection. / Patregnani, Jason T.; Spaeder, Michael C.; Lemon, Valere; Diab, Yaser; Klugman, Darren; Stockwell, David.

In: Joint Commission Journal on Quality and Patient Safety, Vol. 41, No. 3, 01.03.2015, p. 108-114.

Research output: Contribution to journalArticle

@article{d0e74a5223eb4abf8eb674a032c182ea,
title = "Monitoring the harm associated with use of anticoagulants in pediatric populations through trigger-based automated adverse-event detection",
abstract = "Background: The safety profile of anticoagulants, which are being used with increasing frequency in pediatric populations, is not well studied. Automatic triggers built into electronic health record systems (EHR) have been shown to be an effective way to monitor for and identify medication errors. Anticoagulant-associated adverse events were examined through the use of an anticoagulant trigger panel. Methods: In a retrospective, five-year (September 2007-September 2012) observational study, four automated triggers were used to detect anticoagulant-related adverse events: activated partial thromboplastin time (aPTT) > 100 seconds in patients on an unfractionated heparin (UFH) infusion, International Normalized Ratio (INR) > 4, anti-factor Xa (anti-FXa) >1.5U/mL for patients on enoxaparin, and the documented use of protamine. Results: For the 1,664 triggers evaluated, 12 were associated with the aPTT trigger, only 1 of which was preventable. Receiver operator characteristic curve analysis indicated that increasing the aPTT trigger > 140 seconds would optimize sensitivity and specificity. The INR trigger identified four outpatients with adverse events. No adverse events were associated with the anti-FXa trigger. The protamine trigger identified 12 adverse events and was associated with more severe events. Minimal overlap was found with protamine and aPTT triggers. Conclusion: Laboratory- and medication-based triggers can be effective monitoring tools for anticoagulants. For patients receiving a UFH infusion, an aPTT cutoff value of > 140 seconds is more precise. We also found that protamine use as a trigger adds value to a trigger-based anticoagulant monitoring system. Continued improvement in the logic algorithms associated with the EHR-based trigger tool will allow expanded use of this tool in a clinical manner.",
author = "Patregnani, {Jason T.} and Spaeder, {Michael C.} and Valere Lemon and Yaser Diab and Darren Klugman and David Stockwell",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/S1553-7250(15)41015-3",
language = "English (US)",
volume = "41",
pages = "108--114",
journal = "Joint Commission Journal on Quality and Patient Safety",
issn = "1553-7250",
publisher = "Joint Commission Resources, Inc.",
number = "3",

}

TY - JOUR

T1 - Monitoring the harm associated with use of anticoagulants in pediatric populations through trigger-based automated adverse-event detection

AU - Patregnani, Jason T.

AU - Spaeder, Michael C.

AU - Lemon, Valere

AU - Diab, Yaser

AU - Klugman, Darren

AU - Stockwell, David

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Background: The safety profile of anticoagulants, which are being used with increasing frequency in pediatric populations, is not well studied. Automatic triggers built into electronic health record systems (EHR) have been shown to be an effective way to monitor for and identify medication errors. Anticoagulant-associated adverse events were examined through the use of an anticoagulant trigger panel. Methods: In a retrospective, five-year (September 2007-September 2012) observational study, four automated triggers were used to detect anticoagulant-related adverse events: activated partial thromboplastin time (aPTT) > 100 seconds in patients on an unfractionated heparin (UFH) infusion, International Normalized Ratio (INR) > 4, anti-factor Xa (anti-FXa) >1.5U/mL for patients on enoxaparin, and the documented use of protamine. Results: For the 1,664 triggers evaluated, 12 were associated with the aPTT trigger, only 1 of which was preventable. Receiver operator characteristic curve analysis indicated that increasing the aPTT trigger > 140 seconds would optimize sensitivity and specificity. The INR trigger identified four outpatients with adverse events. No adverse events were associated with the anti-FXa trigger. The protamine trigger identified 12 adverse events and was associated with more severe events. Minimal overlap was found with protamine and aPTT triggers. Conclusion: Laboratory- and medication-based triggers can be effective monitoring tools for anticoagulants. For patients receiving a UFH infusion, an aPTT cutoff value of > 140 seconds is more precise. We also found that protamine use as a trigger adds value to a trigger-based anticoagulant monitoring system. Continued improvement in the logic algorithms associated with the EHR-based trigger tool will allow expanded use of this tool in a clinical manner.

AB - Background: The safety profile of anticoagulants, which are being used with increasing frequency in pediatric populations, is not well studied. Automatic triggers built into electronic health record systems (EHR) have been shown to be an effective way to monitor for and identify medication errors. Anticoagulant-associated adverse events were examined through the use of an anticoagulant trigger panel. Methods: In a retrospective, five-year (September 2007-September 2012) observational study, four automated triggers were used to detect anticoagulant-related adverse events: activated partial thromboplastin time (aPTT) > 100 seconds in patients on an unfractionated heparin (UFH) infusion, International Normalized Ratio (INR) > 4, anti-factor Xa (anti-FXa) >1.5U/mL for patients on enoxaparin, and the documented use of protamine. Results: For the 1,664 triggers evaluated, 12 were associated with the aPTT trigger, only 1 of which was preventable. Receiver operator characteristic curve analysis indicated that increasing the aPTT trigger > 140 seconds would optimize sensitivity and specificity. The INR trigger identified four outpatients with adverse events. No adverse events were associated with the anti-FXa trigger. The protamine trigger identified 12 adverse events and was associated with more severe events. Minimal overlap was found with protamine and aPTT triggers. Conclusion: Laboratory- and medication-based triggers can be effective monitoring tools for anticoagulants. For patients receiving a UFH infusion, an aPTT cutoff value of > 140 seconds is more precise. We also found that protamine use as a trigger adds value to a trigger-based anticoagulant monitoring system. Continued improvement in the logic algorithms associated with the EHR-based trigger tool will allow expanded use of this tool in a clinical manner.

UR - http://www.scopus.com/inward/record.url?scp=84943365910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943365910&partnerID=8YFLogxK

U2 - 10.1016/S1553-7250(15)41015-3

DO - 10.1016/S1553-7250(15)41015-3

M3 - Article

C2 - 25977126

AN - SCOPUS:84943365910

VL - 41

SP - 108

EP - 114

JO - Joint Commission Journal on Quality and Patient Safety

JF - Joint Commission Journal on Quality and Patient Safety

SN - 1553-7250

IS - 3

ER -